Cabaletta Bio

(NASDAQ) CABA

Current Price$3.01

Market Cap$476.12M

Since IPO (2019)-70%

5 Year-59%

1 Year+79%

1 Month-21%

Cabaletta Bio Financials at a Glance

Market Cap

$476.12M

Revenue (TTM)

$0.00

Net Income (TTM)

-$175.43M

EPS (TTM)

-$1.97

P/E Ratio

-1.48

Dividend

$0.00

Beta (Volatility)

1.55 (High)

Dividend

$0.00

Beta (Volatility)

1.55 (High)

Price

$3.01

Volume

433,317

Open

$2.89

Price

$3.01

Volume

433,317

Open

$2.89

Previous Close

$3.01

Daily Range

$2.84 - $3.08

52-Week Range

$1.26 - $4.23

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.55 (High)

Price

$3.01

Volume

433,317

Open

$2.89

Previous Close

$3.01

Daily Range

$2.84 - $3.08

52-Week Range

$1.26 - $4.23

Estimated Earnings Date

Aug 6, 2026

CABA News

Cabaletta Bio (CABA) Q2 Loss Widens 30%

Motley Fool Markets TeamAug 7, 2025

scientist looking through microscope (2)

Why Shares of Cabaletta Bio Are Up Tuesday

James HalleyJul 18, 2023

CABA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cabaletta Bio

Industry

Biotechnology

Sector

Health Care

Employees

156

CEO

Steven Nichtberger, MD

Website

www.cabalettabio.com

Headquarters

Philadelphia, PA 19104, US

CABA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-131.58%

Return on Capital

-123.78%

Return on Assets

-118.42%

Earnings Yield

-67.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$476.12M

Shares Outstanding

163.06M

Volume

433.32K

Avg. Volume

3.80M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$179.40M

EBITDA

-$171.58M

Operating Cash Flow

-$142.84M

Capital Expenditure

-$444.00K

Free Cash Flow

-$143.28M

Cash & ST Invst.

$116.64M

Total Debt

$26.45M

Cabaletta Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$476.12M

N/A

Market Cap/Employee

$2.96M

N/A

Employees

161

N/A

Net Income

-$43.52M

-21.1%

EBITDA

-$42.54M

-21.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$116.64M

-11.5%

Total Debt

$26.45M

-8.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$3.33M

-65.3%

Short Term Debt

$23.12M

+20.4%

Return on Assets

-1.18%

N/A

Return on Invested Capital

-1.68%

N/A

Free Cash Flow

-$42.56M

-34.7%

Operating Cash Flow

-$42.56M

-38.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ALLOAllogene Therapeutics, Inc.

ALLOAllogene Therapeutics, Inc.$2.13+3.40%

LXEOLexeo Therapeutics, Inc. Common Stock

LXEOLexeo Therapeutics, Inc. Common Stock$4.75+1.06%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$8.44+2.93%

AVIRAtea Pharmaceuticals, Inc.

AVIRAtea Pharmaceuticals, Inc.$4.49+3.22%

EDITEditas Medicine, Inc.

EDITEditas Medicine, Inc.$2.85+4.01%

LYELLyell Immunopharma, Inc.

LYELLyell Immunopharma, Inc.$11.61-7.05%

PRQRProQR Therapeutics N.V.

PRQRProQR Therapeutics N.V.$1.53-2.24%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$192.53-0.02%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.23+0.00%

ONDSOndas

ONDSOndas$7.83+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

HLHecla Mining

HLHecla Mining$15.54+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

Questions About CABA

What is the current price of Cabaletta Bio?

Cabaletta Bio is trading at $3.01 per share.

What is the 52-week range for Cabaletta Bio?

Over the past 52 weeks, Cabaletta Bio has traded between $1.26 and $4.23.

How much debt does Cabaletta Bio have?

As of the most recent reporting period, Cabaletta Bio reported total debt of $26.45M.

How much cash does Cabaletta Bio have on hand?

Cabaletta Bio reported $116.64M in cash and cash equivalents in its most recent financial results.

What is Cabaletta Bio’s dividend yield?

Cabaletta Bio does not currently have a dividend yield.

Cabaletta Bio

Cabaletta Bio Financials at a Glance

CABA News

Cabaletta Bio (CABA) Q2 Loss Widens 30%

Why Shares of Cabaletta Bio Are Up Tuesday

CABA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cabaletta Bio

CABA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cabaletta Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CABA

What is the current price of Cabaletta Bio?

What is the 52-week range for Cabaletta Bio?

How much debt does Cabaletta Bio have?

How much cash does Cabaletta Bio have on hand?

What is Cabaletta Bio’s dividend yield?

Premium Investing Services